It helps detoxify the body, preventing fatigue linked to toxin buildup
the clinical evidence in humans especially for compounded injectable formulations specifically is more limited
Clinical examination Full skin examination assess for hyperextensibility of the skin and abnormal scarring The Beighton scale assess for hypermobility of a joint, in which a score of 5 or more indicates generalised joint hypermobility Investigations Skin biopsy for histology, fibroblast culture, and electron microscopy When suspecting kyphoscoliotic EDS, a urine sample is taken to measure the ratio of lysyl-pyridinoline to hydroxylysyl-pyridinoline cross-links Molecular genetic testing confirms the diagnosis, except in the case of hypermobile EDS, which has an unknown genetic basis and so is a clinical diagnosis which must meet all the clinical criteria
Accurate dosage preparation improves reliability of every injection or dose
No serious adverse events have been documented in the peer-reviewed literature at research-relevant doses
Here is the complete breakdown for the recommended 3 mL reconstitution (3.33 mg/mL)